Neogen Corporation

Neogen Corporation

NEOGยทNASDAQ

$8.81

-1.2%
HealthcareMedical - Diagnostics & Research

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

At a Glance

Live Snapshot
Market Cap$1.92B
EPS-5.0300
P/E Ratio-1.75
Earnings Date07/28/2026
3Y+70.0%
5Y+114.0%
10Y+178.0%
3Y-2361.0%
5Y-1936.0%
10Y-3087.0%
3Y-14.0%
5Y-32.0%
10Y+65.0%
Neogen Corporation

Neogen Corporation Profit Bridge

NEOG ยท NASDAQ
Revenue894.66M
Cost of Goods Sold (473.29M)
Gross Profit421.38M
Operating Expenses (411.96M)
Operating Income9.42M
Interest Expense (71.62M)
Other Income/Expense-1.14B
Pretax Income-1.13B
Income Tax (-41.07M)
Net Income-1.09B
Net Income
-1.09B

Profitability Analysis

Gross Margin

47.1%

Strong gross margins indicate healthy pricing and efficient production or service delivery.

Operating Margin

1.1%

Minimal operating profit suggests high operating costs or pricing challenges. Scalability is concerning.

Net Profit Margin

-122.1%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

Neogen Corporation Income Statement

NEOG โ€ข NASDAQ

Neogen Corporation Income StatementMay 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010May 2009May 2008May 2007May 2006
REVENUE
894.7M
924.2M
822.4M
527.2M
468.5M
418.2M
414.2M
397.9M
361.6M
321.3M
283.1M
247.4M
207.5M
184M
172.7M
140.5M
118.7M
102.4M
86.1M
72.4M
GROSS PROFIT
(473.3M)
(461.6M)
(416.5M)
(284.1M)
(253.4M)
(221.9M)
(222.3M)
(211.7M)
(189.6M)
(168.2M)
(143.4M)
(124.8M)
(98M)
(91.6M)
(84.9M)
(67.5M)
(59.3M)
(49.2M)
(41.6M)
(35.4M)
421.4M
462.6M
406M
243M
215.1M
196.3M
191.9M
186.3M
172M
153.1M
139.7M
122.6M
109.5M
92.4M
87.8M
73M
59.4M
53.2M
44.6M
37M
OPERATING INCOME
(412M)
(385.2M)
(368.4M)
(184.4M)
(140.9M)
(128.8M)
(123.8M)
(116.1M)
(107M)
(96.7M)
(86.6M)
(79.2M)
(68.8M)
(58.7M)
(52M)
(46.1M)
(38.9M)
(35.2M)
(31.1M)
(26.2M)
(402M)
(382.8M)
(342.4M)
(167.3M)
(124.6M)
(114M)
(111M)
(105.2M)
(96.6M)
(86.8M)
(77M)
(70.9M)
(61M)
(52.1M)
(45.1M)
(39.8M)
(34.4M)
(31.6M)
(27.8M)
(23.2M)
(21.1M)
(22.5M)
(26M)
(17M)
(16.2M)
(14.8M)
(12.8M)
(10.9M)
(10.4M)
(9.9M)
(9.6M)
(8.3M)
(7.8M)
(6.6M)
(6.8M)
(6.3M)
(4.6M)
(3.6M)
(3.3M)
(3M)
9.4M
77.4M
37.5M
58.6M
74.2M
67.5M
68.1M
70.2M
64.9M
56.4M
53.1M
43.4M
40.7M
33.7M
35.8M
26.9M
20.5M
18M
13.5M
10.8M
PRE-TAX INCOME
(71.6M)
(73.4M)
(56M)
(72K)
(78K)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-68.5M
-67M
-52.8M
1.3M
1.6M
6M
4.7M
2M
838K
322K
228K
115K
144K
107K
95K
81K
248K
0.0
0.0
0.0
-9M
-20M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-1.1B
-91.7M
-59.6M
1.6M
1.1M
4.8M
4.9M
3.3M
1.7M
-873K
-1M
-360K
435K
224K
-596K
442K
1.1M
479K
371K
46K
-1.1B
-14.3M
-22M
60.2M
75.3M
72.3M
73M
73.5M
66.7M
55.5M
52.1M
43M
41.1M
34M
35.2M
27.3M
21.6M
18.5M
13.9M
12.1M
NET INCOME
-41.1M
-4.9M
(828K)
(11.9M)
(14.4M)
(12.8M)
(12.8M)
(10.3M)
(22.7M)
(19M)
(18.5M)
(15M)
(14.1M)
(11.5M)
(12.4M)
(9.8M)
(7.8M)
(6.4M)
(4.8M)
(4.2M)
-1.1B
-9.4M
-22.9M
48.3M
60.9M
59.5M
60.2M
63.1M
43.8M
36.6M
33.5M
28.2M
27.2M
22.5M
22.8M
17.5M
13.9M
12.1M
9.1M
7.9M

SEC Filings

NEOG - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

April 20, 2026
April 20, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 09, 2026
February 28, 2026
2026
8-K

8-K 2026

N/A

April 09, 2026
April 09, 2026
2026
8-K

8-K 2026

N/A

March 30, 2026
March 30, 2026
2026
8-K

8-K 2026

N/A

January 08, 2026
January 08, 2026
2026
10-Q

10-Q 2025 Q4

Q4

January 08, 2026
November 30, 2025
2025
8-K

8-K 2025

N/A

October 30, 2025
October 30, 2025
2025
8-K/A

8-K/A 2025 (Amended)

N/A

October 28, 2025
August 14, 2025
2025
8-K

8-K 2025

N/A

October 27, 2025
October 23, 2025
2025
8-K/A

8-K/A 2025 (Amended)

N/A

October 27, 2025
October 23, 2025
2025
Showing 1 to 10 of 393 filings